Want to see IN:ASTERDM full AI Analyst Report?
ASTERDM Stock Chart & Stats
₹615.20
-₹6.20(-1.19%)
At close: 4:00 PM EST
₹615.20
-₹6.20(-1.19%)
Day’s Range― - ―
52-Week Range₹519.80 - ₹890.95
Previous CloseN/A
Volume549.11K
Average Volume (3M)421.97K
Market Cap
₹658.85B
Enterprise Value₹358.85K
Total Cash (Recent Filing)₹13.27B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)122.6
Beta0.63
Next Earnings
Nov 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.53%
Share Statistics
EPS (TTM)6.17
Shares Outstanding871,672,400
10 Day Avg. Volume73,739
30 Day Avg. Volume421,971
Financial Highlights & Ratios
PEG Ratio-0.96
Price to Book (P/B)7.55
Price to Sales (P/S)7.44
P/FCF Ratio171.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)13.49
Revenue Forecast (FY)₹103.17B
Bulls Say, Bears Say
Bulls Say
Improving Profitability And RevenuePositive revenue growth alongside solid EBITDA and EBIT margins indicates stronger operating performance across the healthcare network. If maintained, this combination can support reinvestment, improve earnings resilience, and strengthen the company’s ability to scale facilities and services.
Lower Financial LeverageThe substantial reduction in debt-to-equity improves financial flexibility and reduces the balance-sheet burden compared with prior years. Lower leverage can leave more capacity to fund expansion, manage operational volatility, and withstand periods of weaker healthcare demand or profitability.
Free Cash Flow RecoveryA return to positive free cash flow is an important improvement in internal funding capacity after the FY2024 shortfall. Sustained cash generation would support capital investment, debt management, and shareholder or strategic initiatives without relying as heavily on external financing.
Bears Say
Volatile Earnings QualityThe sharp variation in revenue, net income, and margins makes it harder to establish a dependable earnings trend. An unusually large FY2025 profit spike may not represent recurring operating performance, reducing confidence in the durability and predictability of reported earnings.
Inconsistent Cash ConversionModerate conversion of accounting profit into cash can limit the resources available for reinvestment, debt reduction, and other capital allocation priorities. Continued variation in operating cash flow suggests that working-capital or timing effects may weaken the reliability of earnings-based cash generation.
Negative EPS GrowthNegative EPS growth indicates that per-share earnings have not kept pace over the measured period, even as the broader financial profile improved. Unless reversed, this can constrain the company’s ability to compound shareholder earnings and may signal pressure on profitability or share-level outcomes.
Aster DM Healthcare Ltd. News
ASTERDM FAQ
What was Aster DM Healthcare Ltd.’s price range in the past 12 months?
Aster DM Healthcare Ltd. lowest stock price was ₹519.80 and its highest was ₹890.95 in the past 12 months.
What is Aster DM Healthcare Ltd.’s market cap?
Aster DM Healthcare Ltd.’s market cap is ₹658.85B.
When is Aster DM Healthcare Ltd.’s upcoming earnings report date?
Aster DM Healthcare Ltd.’s upcoming earnings report date is Nov 05, 2026 which is in 44 days.
How were Aster DM Healthcare Ltd.’s earnings last quarter?
Aster DM Healthcare Ltd. released its earnings results on Aug 05, 2026. The company reported ₹1.4 earnings per share for the quarter, missing the consensus estimate of ₹2.3 by -₹0.9.
Is Aster DM Healthcare Ltd. overvalued?
According to Wall Street analysts Aster DM Healthcare Ltd.’s price is currently Overvalued.
Does Aster DM Healthcare Ltd. pay dividends?
Aster DM Healthcare Ltd. pays a Semiannually dividend of ₹3 which represents an annual dividend yield of 0.53%. See more information on Aster DM Healthcare Ltd. dividends here
What is Aster DM Healthcare Ltd.’s EPS estimate?
Aster DM Healthcare Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aster DM Healthcare Ltd. have?
Aster DM Healthcare Ltd. has 871,672,400 shares outstanding.
What happened to Aster DM Healthcare Ltd.’s price movement after its last earnings report?
Aster DM Healthcare Ltd. reported an EPS of ₹1.4 in its last earnings report, missing expectations of ₹2.3. Following the earnings report the stock price went up 0.737%.
Which hedge fund is a major shareholder of Aster DM Healthcare Ltd.?
Currently, no hedge funds are holding shares in IN:ASTERDM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aster DM Healthcare Ltd.
Aster DM Healthcare Ltd. operates as an international healthcare provider with a significant presence in India and other global regions. The company's operations are segmented across hospitals, clinics, retail pharmacies, and other diversified services. It delivers a comprehensive range of medical care, from fundamental primary care to highly specialized quaternary services, supported by a vast infrastructure. This network includes 29 hospitals, 120 clinics, 371 retail pharmacies, 114 laboratories, and numerous patient experience centers, all operating under well-known brands such as Aster, Medcare, and Access. Beyond direct patient care, the company also provides healthcare retailing, diagnostic testing, digital health solutions, and medical education. Established in 1987, Aster DM Healthcare maintains its corporate headquarters in Dubai, United Arab Emirates.
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Global Health Limited
―
Narayana Hrudayalaya Ltd.
―